JOHNSON & JOHNSON New Brunswick, NJ (December 7th, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the 41st Annual J.P. Morgan Healthcare Conferenceon Monday, January 9th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman Elect of the Board and Chief Executive Officer will represent the Company in a session scheduled at 12:45 p.m. (Eastern Time).
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs after the webcast.
-
Investor Contact:
RA-JJCUS-InvestorRel@ITS.JNJ.comMedia Contact:
Jake Sargent
(732) 524-1090
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Johnson & Johnson published this content on 07 December 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 December 2022 16:11:04 UTC.
